AMANDA HELM: Open Payments
NPI 1679931067 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,057 in 60 payments from 22 companies in 2025. Trend: 2023 $978 · 2024 $869 · 2025 $1,057
Food & beverage: $1,057
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $173 |
| Novartis Pharmaceuticals Corporation | 8 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $103 |
| Novo Nordisk Inc | 5 | $87 |
| Dexcom, Inc. | 3 | $67 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Astellas Pharma US Inc | 2 | $48 |
| Calliditas Therapeutics US Inc. | 2 | $44 |
| ABBVIE INC. | 2 | $40 |
Products named: LEQVIO, OTEZLA, Dexcom G6 Transmitter, CAMZYOS, TRINTELLIX, EVENITY, Auvelity, Veozah.
Industry payments across ND — which companies pay providers there.
